Keyphrases
Antibody Conjugates
100%
Anti-surfactant
100%
Selective Targeting
100%
Lipoplexes
100%
Respiratory Epithelial Cells
100%
Alveolar Type II Cells
100%
SP-C
100%
Alveolar Type II
100%
Pulmonary Inflammation
18%
Cell Dysfunction
18%
Viscera
18%
MiR-486
18%
MicroRNA
9%
Quantitative PCR
9%
Aqueous Layer
9%
Significant Level
9%
Lung
9%
C57BL
9%
Drug Delivery System
9%
Therapeutic Target
9%
Desired Characteristics
9%
Effective Compounds
9%
Pulmonary Fibrosis
9%
4-fold
9%
Acute Lung Injury
9%
Carrier System
9%
Specific Antigen
9%
Nanoparticle Carrier
9%
Pulmonary Disease
9%
Specific Drug Delivery
9%
Pulmonary Edema
9%
Disease Pathogenesis
9%
Hypoxemia
9%
Lung Damage
9%
Lung Dysfunction
9%
Pulmonary Adenocarcinoma
9%
Cell-type Specificity
9%
Normal Lung Function
9%
Nares
9%
Surfactant Films
9%
No Weight Loss
9%
Alveolar Surfactant
9%
Systemic Spread
9%
Lung Cell Types
9%
RNA Delivery
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lipoplex
100%
Antibody Conjugate
100%
Surfactant Protein C
100%
Pneumonia
28%
Disease
14%
Drug Delivery System
14%
Lung Adenocarcinoma
14%
Side Effect
14%
Nanoparticle
14%
C57BL 6 Mouse
14%
Lung Disease
14%
microRNA
14%
Lung Fibrosis
14%
Acute Lung Injury
14%
Hypoxemia
14%
Lung Injury
14%
Lung Edema
14%
Pulmonary Surfactant
14%